Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy.

Mizui, T; Teramachi, H; Tachi, T; Tamura, K; Shiga, H; Komada, N; Umeda, M; Koda, A; Aoyama, S; Goto, C; Tsuchiya, T

Mizui, T; Teramachi, H; Tachi, T; Tamura, K; Shiga, H; Komada, N; Umeda, M; Koda, A; Aoyama, S; Goto, C; Tsuchiya, T.

Affiliation

Mizui T; Department of Pharmacy, Gifu Municipal Hospital, Gifu, Japan.

Pharmazie ; 68(8): 706-10, 2013 Aug.

Article de En | MEDLINE | ID: mdl-24020129

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Entérocolite pseudomembraneuse / Clostridioides difficile / Probiotiques / Diarrhée Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male Langue: En Journal: Pharmazie Sujet du journal: FARMACIA Année: 2013 Type de document: Article Pays d'affiliation: Japon Pays de publication: Allemagne

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links